コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 g policy as a result of the backlash against managed care.
2 icists--to develop a statement of ethics for managed care.
3 ions about quality, and dissatisfaction with managed care.
4 he VA system than for patients in commercial managed care.
5 p to avoid a large proportion of disputes in managed care.
6 eficiaries who were and were not enrolled in managed care.
7 l disparity in vaccination is not reduced in managed care.
8 re African American and 11% were enrolled in managed care.
9 s may not be fulfilled due to pressures from managed care.
10 o substance abuse treatment after a shift to managed care.
11 ars and enrolled in Medicare FFS or Medicare managed care.
12 1994 to 7.7% in 1997, following the shift to managed care.
13 ment, collaborative care, enhanced care, and managed care.
14 f the same specific clinical competencies in managed care.
15 service medicine, and 29.3 percent preferred managed care.
16 ine their experiences in and perspectives on managed care.
17 zations can be influenced by the presence of managed care.
18 service medicine, and 20.5 percent preferred managed care.
19 atient-physician relationship as a result of managed care.
20 cost-effectiveness depend on good clinically managed care.
21 determine how best to inform patients about managed care.
22 difference in societal costs associated with managed care.
24 , Diagnostic, and Treatment dental services; managed care accountability; integration of medical and
25 y enrollment rate and two measures of county managed care activity (penetration and index of competit
28 viously documented negative attitudes toward managed care among academic physicians may obscure an un
30 arize some of the complex issues surrounding managed care and discuss the resultant changes in anesth
31 variation of health plan exit from Medicaid managed care and evaluate the relationship between healt
32 care utilization and outcomes of persons in managed care and fee-for-service after adjusting for dif
34 between patients in HMOs and those in other managed care and fee-for-service settings in rates of in
35 y to use biologic agents than those in other managed care and fee-for-service settings, primarily due
36 d other treatments among patients with RA in managed care and fee-for-service settings, with and with
38 he current and potential long-term impact of managed care and other system changes on the practice of
39 ween financial and administrative aspects of managed care and physicians' concern about the scope of
40 mics, discussing physician organizations and managed care, and a medical ethics evaluation of medical
41 o understand and exercise other rights under managed care, and discourage use of compensation methods
42 with changes in reimbursement, increases in managed care, and growth in the prescription of medicati
44 d whether the ascendancy of computerization, managed care, and the adoption of more businesslike appr
45 ed antidepressants, increased penetration of managed care, and the development of rapid and efficient
47 ing caused by the transition into a Medicaid managed care arrangement or Medicaid ineligibility (the
50 dvisory patterns using a national integrated managed care claims database from July 1999 through June
51 fter an acute hospitalization at a time when managed care companies and others increasingly hold hosp
52 5 to 64 years belonging to a large, national managed care company from January 1, 2005, to December 3
53 In the multivariate model, greater county managed care competition (IOC) was inversely related to
54 counties, and counties with higher levels of managed care competition had significantly lower enrollm
55 was Kaiser Permanente Hawaii, an integrated managed care consortium that serves approximately 15% of
59 re conducted using data from a US integrated managed care database (PharMetrics claims database) from
60 tive cohort analysis using data from a large managed care database (PharMetrics, 2000-2006), patients
63 f patients with RA in managed care, those in managed care did not differ from those in fee-for-servic
64 therapy visits in 1999, patients with RA in managed care did not report significantly different util
68 D who were commercially insured and Medicare managed care enrollees from a large, national US managed
75 ve), more fee-for-service beneficiaries than managed-care enrollees underwent angiography (46 percent
76 ollment in Medicaid or low-income subsidies, managed care enrollment, region and rurality of residenc
78 to prepare physicians to work effectively in managed care environments, managed care is often perceiv
83 ectors, and department chairs responded that managed care had reduced the time they had available for
93 beneficiaries who were enrolled in Medicare managed care health plans had data for at least 1 of the
95 Among Medicare beneficiaries enrolled in managed care health plans, blacks received poorer qualit
99 e-for-service medicine was rated better than managed care in terms of access (by 80.2 percent of resp
100 section is important from the perspective of managed care in the United States and for the commission
103 nsurance (n = 18,905), patients with private managed care insurance (n=7169) and Medicare managed car
104 managed care insurance (n=7169) and Medicare managed care insurance (n=880) were less likely to recei
105 , we examined whether patients with Medicare managed care insurance enrolled in hospice earlier and h
106 New York State; however, the extent to which managed care insurance plans direct enrollees to the low
107 State with private managed care and Medicare managed care insurance were significantly less likely to
109 ly to undergo reconstruction than those with managed care insurance; however, there was no difference
114 rk effectively in managed care environments, managed care is often perceived negatively by academic p
117 r data indicate that residency directors and managed care medical directors value mastery of many of
118 ps," on drug benefits are common in Medicare managed care (Medicare + Choice) and have been part of s
119 s' experiences with health care for Medicare managed care (MMC) and traditional fee-for-service (FFS)
122 ir scope of practice, and a proliferation of managed-care models that emphasized the use of these pro
123 ntinuously enrolled in a large nationwide US managed care network and who visited an eye care profess
124 ed for more than 6 months in a nationwide US managed care network between 2001 and 2011 in communitie
125 olled for 3 or more years in a nationwide US managed care network between January 1, 2001, and Decemb
128 55 years who were continuously enrolled in a managed care network for at least 2 years and who had >/
129 o were continuously enrolled in a particular managed care network for at least 5 years between Januar
130 d no preexisting record of OAG in a large US managed care network from January 1, 2001, through Decem
131 th newly diagnosed diabetes enrolled in a US managed care network from January 1, 2001, through Decem
132 ctomy rates per 1000 enrollees in this large managed care network over the course of the past decade.
135 ims data from a large national United States managed care network were reviewed to identify Asian Ame
136 G patients enrolled in a large United States managed care network were reviewed to identify glaucoma-
137 nrollees in a large nationwide United States managed care network with newly diagnosed acute conjunct
139 cataracts who were enrolled in a nationwide managed-care network during the period from 2001 to 2011
140 of almost 8 million enrollees in a national managed-care network throughout the United States who ha
141 sons continuously enrolled for 11 years in a managed-care network were searched for International Cla
144 ood out as a low and slow payer, but neither managed care nor Medicare had a consistent effect on fin
146 Respondents rated their attitudes toward managed care on a 0-to-10 scale, with 0 defined as "as n
147 ad better scores than patients in commercial managed care on all process measures (for example, 93% v
150 assessed the trends for visits covered by a managed-care or other prepaid health plan (prepaid visit
151 rospective study was done among members of a managed care organization in Minneapolis/St. Paul, Minne
153 t Kaiser Permanente Hawaii, a multispecialty managed care organization serving approximately 15% of t
154 he case patients were matched to controls by managed care organization site, sex, and age at the inde
159 ical records of 452 patients from a regional managed care organization with >/=3 consecutive NSAID pr
160 rom Kaiser Permanente Southern California, a managed care organization with more than 3 million membe
161 -years]), was evaluated using records from a managed care organization with nearly 20 community hospi
164 patients with heart failure in an integrated managed care organization, low health literacy was signi
168 isits (1996-1999) from a large Massachusetts managed care organization/multispecialty practice group
171 e in the relationship between themselves and managed care organizations (MCOs), including how it can
173 crete definition of primary care has allowed managed care organizations and payers, among others, to
175 years of age or older who were enrolled in 2 managed care organizations and received care between Jul
177 care for individuals who are not covered by managed care organizations can be influenced by the pres
178 older who were continuously enrolled in the managed care organizations from 1 July 1998 to 31 July 1
179 Consecutive patients (N=27,332) from six managed care organizations in five states were screened,
180 ician visits were obtained from Medicare and managed care organizations in the Philadelphia region.
181 f significant medically attended events at 8 managed care organizations in the United States that com
182 ieties, influenza vaccine manufacturers, and managed care organizations met to assess whether current
187 seniors (adults aged >/=65 years) from 7 US managed care organizations that participated in the Vacc
188 with the vision behind the creation of HMOs, managed care organizations that were once embraced by ph
189 ct that the new HEDIS measure will encourage managed care organizations to develop systems that impro
190 well as court decisions increasingly require managed care organizations to disclose physician financi
192 the generalizability of these findings in 2 managed care organizations to the general geriatric popu
193 m 46 primary care practices in 6 nonacademic managed care organizations were enrolled in a randomized
194 fairs (VA) with that delivered in commercial managed care organizations, nor have studies focused in
195 ervice to patients, surgeons, hospitals, and managed care organizations, thereby securing the future
200 of community-dwelling members of three large managed-care organizations who were at least 65 years ol
206 teristics, process of care, and outcomes for managed care patients who received new antidepressant pr
209 , physicians who practice in areas with high managed care penetration provided fewer hours of charity
210 showed that departments with medium to high managed care penetration reported more dissatisfaction i
211 ns and those who practice in areas with high managed care penetration tend to provide less charity ca
213 ncology from areas with low, medium, or high managed care penetration were asked to complete a questi
214 tics, and local market factors (for example, managed care penetration); the difference in perceived a
215 tile v lowest quartile) after accounting for managed care penetration, proportion uninsured, and othe
218 epair with vitrectomy among a large group of managed care plan beneficiaries throughout the United St
219 rs who were enrolled in a United States (US)-managed care plan for >/=7 years between 2001 and 2012 a
222 Since the study was done in the context of a managed care plan in one geographic area, it could not a
223 Claims data from a large California Medicaid managed care plan that began offering teledermatology as
225 rom women 50 years or older enrolled in a US managed-care plan for at least 4 years in which enrollee
228 pective cohort of all comprehensive Medicaid managed care plans (N = 390) during the interval 2006-20
231 our findings raise the possibility that some managed care plans are more successful at facilitating o
232 rom a national integrated claims database of managed care plans from October 1998 to September 2005 (
233 large national integrated claims database of managed care plans from October 1998 to September 2005 (
234 ysicians to collectively negotiate fees with managed care plans has been introduced in 10 state legis
237 This was the case well before the rules of managed care plans required patients to align themselves
238 at least 85% of their practice revenue from managed care plans were considerably less likely to prov
240 tion of approximately 800,000 members from 4 managed care plans, we identified patients who had at le
243 aid and commercial populations in 3 types of managed care plans: Medicaid-only plans (serving predomi
246 f care for elderly Medicare beneficiaries in managed-care plans improved substantially from 1997 to 2
247 ten among Medicare beneficiaries enrolled in managed-care plans than among those with fee-for-service
248 rmed less frequently in patients enrolled in managed-care plans than in those with fee-for-service co
249 and black beneficiaries enrolled in Medicare managed-care plans who were eligible for at least one of
254 ted foreclosure among a continuously insured managed-care population of persons with type 2 diabetes
255 pressed primary care patients implemented by managed care practices can improve health outcomes 5 yea
257 <15 years) enrolled in Tennessee's Medicaid Managed Care Program in the 4 study counties, representi
260 potentially duplicative funds in 2 separate managed care programs for the care of same individuals.
264 s had a mean of greater than 10% of Medicaid managed care recipients enrolled in plans that exited, w
265 p of stakeholders--patients, physicians, and managed care representatives, along with medical ethicis
266 0%) household survey respondents, 51 (23.4%) managed care respondents, and 173 (57.7%) NYU Langone re
271 y to use biologic agents than those in other managed care settings (difference of -6.6%; 95% confiden
272 5%; 95% CI -19.0%, -5.9%); patients in other managed care settings and fee-for-service did not differ
273 ignificantly less likely than those in other managed care settings to initiate the use of biologic ag
274 ors, and corticosteroids than those in other managed care settings; they were also less likely to use
276 Managed care status in 1994, and change in managed care status between 1994 and 1999, were not asso
278 te the impact of health insurance status and managed care status on the health care expenditures of t
279 003 household survey [n = 119] and 2004-2005 managed care subscriber survey [n = 218]) who completed
280 sons who were enrolled in one large regional managed care system and treated for AF during calendar y
281 s in a geographically dispersed 280-hospital managed-care system from 2005 to 2014 were reviewed.
284 iews office economics, this year focusing on managed care, the physician workforce, practice manageme
285 wth in the proportion of patients with RA in managed care, those in managed care did not differ from
289 fferences in readmission rates were seen for managed care versus fee-for-service or capitated versus
290 extensively on self-pay patients, had fewer managed-care visits, and prescribed medications in fewer
291 uartile range) length of stay was longer for managed care vs FFS patients (32 days [11-82] vs 25 days
292 Hospice enrollment and length of stay among managed care vs FFS patients differed significantly by r
298 as possible." The expressed attitudes toward managed care were negative, ranging from a low mean (+/-
300 The changes in the sources of payment and managed care will directly affect the economics of a phy